Primary Biliary Cirrhosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, IntrahepaticInterventions: Drug: GSK2330672; Drug: Placebo; Drug: Ursodeoxycholic acidSponsor: GlaxoSmithKlineRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, IntrahepaticInterventions: Drug: GSK2330672; Drug: Placebo; Drug: Ursodeoxycholic acidSponsor: GlaxoSmithKlineRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, IntrahepaticInterventions: Drug: GSK2330672; Drug: Placebo; Drug: Ursodeoxycholic acidSponsor: GlaxoSmithKlineRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, IntrahepaticInterventions: Drug: GSK2330672; Drug: Placebo; Drug: Ursodeoxycholic acidSponsor: GlaxoSmithKlineRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials